Hiroomi Tada is Chief Medical Officer of Tyra Biosciences, Inc.. Currently has a direct ownership of 86,435 shares of TYRA, which is worth approximately $1.44 Million. The most recent transaction as insider was on Mar 15, 2024, when has been sold 1,968 shares (Common Stock) at a price of $6.58 per share, resulting in proceeds of $12,949. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 86.4K
0% 3M change
3.98% 12M change
Total Value Held $1.44 Million

Hiroomi Tada Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 15 2024
BUY
Grant, award, or other acquisition
$12,949 $6.58 p/Share
1,968 Added 2.23%
86,435 Common Stock
Sep 15 2023
BUY
Grant, award, or other acquisition
$8,797 $6.58 p/Share
1,337 Added 1.56%
84,467 Common Stock
Mar 15 2023
BUY
Grant, award, or other acquisition
$12,455 $6.58 p/Share
1,893 Added 2.23%
83,130 Common Stock
Sep 15 2022
BUY
Grant, award, or other acquisition
$4,688 $7.66 p/Share
612 Added 0.75%
81,237 Common Stock
Mar 15 2022
BUY
Grant, award, or other acquisition
$23,057 $8.53 p/Share
2,703 Added 3.24%
80,625 Common Stock
HT

Hiroomi Tada

Chief Medical Officer
Carlsbad, CA

Track Institutional and Insider Activities on TYRA

Follow Tyra Biosciences, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells TYRA shares.

Notify only if

Insider Trading

Get notified when an Tyra Biosciences, Inc. insider buys or sells TYRA shares.

Notify only if

News

Receive news related to Tyra Biosciences, Inc.

Track Activities on TYRA